Drug intelligence / Profile preview

qingqiao kangbindu keli

Development stage
Unknown
Lead developer
Buchang Pharmaceuticals
Administration
Oral
01

Overview

Qingqiao Kangbindu Granules is a Traditional Chinese Medicine (TCM) formulation primarily developed and manufactured by Shandong Buchang Pharmaceuticals. It is indicated for the treatment of viral influenza, upper respiratory tract infections, and associated symptoms such as fever, sore throat, and cough. The formulation typically includes botanical extracts such as *Forsythia suspensa* (Qingqiao), *Lonicera japonica* (Honeysuckle), and *Isatis indigotica* (Radix Isatidis), which are traditionally used for their heat-clearing and detoxifying properties. In modern pharmacological terms, these components are studied for their broad-spectrum antiviral and anti-inflammatory activities. The drug is approved by the National Medical Products Administration (NMPA) in China and is widely used as a proprietary Chinese medicine for seasonal respiratory viral infections.

Brand names
青翘Qingqiao
Other names
Qingqiao Kangbindu GranulesQingqiao Antiviral Granules青翘抗病毒颗粒

Beyond the preview

Go deeper on qingqiao kangbindu keli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on qingqiao kangbindu keli.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call